Literature DB >> 31581064

Polyproline chains destabilize the Alzheimer's amyloid-β protofibrils: A molecular dynamics simulation study.

Pavan Krishna Kanchi1, Ashok Kumar Dasmahapatra2.   

Abstract

Alzheimer's is a fatal neurodegenerative disease for which there is no cure at present. The disease is characterized by the presence of plaques, principally comprising the amyloid-β peptide (viz., β-sheet) in the brains of a patient. In our present work, we study the interaction of these β-sheets with a different number of repeating units of proline (β-sheet breaker) by docking and all atom molecular dynamics simulations. Our results indicate that proline can break the amyloid protofibrils apart, cause them to break their β-sheet structure, and in some cases even induce the formation of 310 helices, which may be intermediates in the unfolding of these β-sheets. We have also observed that some of the important hydrogen bonds and salt bridges between chains were disrupted by proline and the tight interatomic packing of atoms in the fibrils was made relatively loose. Proline chains had a tendency to make several contacts with charged residues. Proline chains binded well to the fibrils by strong electrostatic interactions while hydrophobic interactions played a less important role. This leads to the conclusion that proline can break the amyloid fibrils apart and can be considered in the design of novel peptide-based drugs to treat Alzheimer's disease and potentially other diseases caused by the misfolding of proteins into β-sheets.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3(10) helix; Alzheimer’s disease; Amyloid-β fibril; Molecular dynamics simulations; Polyproline; Protein docking

Mesh:

Substances:

Year:  2019        PMID: 31581064     DOI: 10.1016/j.jmgm.2019.107456

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  5 in total

1.  Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic.

Authors:  Shanshan Du; Cláudia Vilhena; Samantha King; Alfredo Sahagún-Ruiz; Sven Hammerschmidt; Christine Skerka; Peter F Zipfel
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

2.  Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology.

Authors:  Pallabi Sil Paul; Jae-Young Cho; Qi Wu; Govindarajan Karthivashan; Emily Grabovac; Holger Wille; Marianna Kulka; Satyabrata Kar
Journal:  J Nanobiotechnology       Date:  2022-02-04       Impact factor: 10.435

3.  Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway.

Authors:  Guangming Li; Sisi Liu; Huili Wang; Rui Pan; Haijie Tang; Xueqin Yan; Yanping Wang; Yongmei Fu; Fujun Jing; Jun Dong
Journal:  Int J Mol Med       Date:  2020-03-20       Impact factor: 4.101

4.  The Impact of Natural Compounds on S-Shaped Aβ42 Fibril: From Molecular Docking to Biophysical Characterization.

Authors:  Stefano Muscat; Lorenzo Pallante; Filip Stojceski; Andrea Danani; Gianvito Grasso; Marco Agostino Deriu
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

Review 5.  Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.

Authors:  Tapan Behl; Ishnoor Kaur; Ovidiu Fratila; Roxana Brata; Simona Bungau
Journal:  Int J Mol Sci       Date:  2020-10-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.